Company intelligence / Profile preview
Therabest
Seoul, South Korea
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Therabest is a clinical-stage biotech company developing next-generation immunotherapies using proprietary platforms based on iPSC-derived immune cells and nano-convergent drug delivery. Its lead programs include enhanced NK cell therapies for oncology and neurodegenerative diseases, with the most advanced asset in Phase 2 trials for atopic dermatitis. The company has demonstrated preclinical efficacy in solid tumors and Alzheimer’s disease models, with ongoing collaborations to expand into exosome-based therapies.[1][3][5]
- Therapeutic areas
- OncologyDermatologyGastroenterologyNeurology
- Modalities
- iPSC-derived immune cells (notably NK cells)CAR-NK cell therapyImmune cell therapyNano-convergence integrated therapeutics (nanoDDS)
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Glycotope GmbH – collaboration to combine TB‑100 with GT–00AxIL15 immuno-cytokine for TNBC.[3]Memel Biotech – MoU to co-develop exosome-based cell therapies; Memel provides manufacturing services from Lithuania while Therabest supplies its EiNK platform.[5]Reyon – joint development of pDNA sample supply business.[1]
Beyond the preview
Go deeper on Therabest.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Therabest.